Breaking News

Yesterday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Options	Aurora Cannabis call volume above normal and directionally bullish » 10:45 03/02/21 03/02 10:45 03/02/21 10:45 ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) Bullish option flow… Bullish option flow detected in Aurora Cannabis with 42,112 calls trading, 1.3x expected, and implied vol increasing almost 10 points to 117.07%. Apr-21 15 calls and 3/5 weekly 12 calls are the most active options, with total volume in those strikes near 11,600 contracts. The Put/Call Ratio is 0.12. Earnings are expected on May 13th. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) 02/22/21 NJ Governor signs bill to legalize adult-use cannabis 02/11/21 Aurora Cannabis jumps 10% to $15.90 after reporting Q2 results 02/11/21 Aurora Cannabis CEO: Aurora had an excellent second quarter 02/11/21 Aurora Cannabis falls -20.3% ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) 02/16/21 CIBC Aurora Cannabis price target raised to C$18.50 from C$17 at CIBC 02/16/21 GLJ Research Aurora Cannabis shares have 100% downside by end of 2022, says GLJ Research 02/12/21 Canaccord Aurora Cannabis price target raised to C$14 from C$11 at Canaccord 02/12/21 MKM Partners Aurora Cannabis downgraded to Sell from Neutral at MKM Partners ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) 02/11/21 Aurora Cannabis reports Q2 revenue C$67.67M, vs. C$55.14M a year ago 11/09/20 Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4 10/30/20 Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance 09/22/20 Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4 22 Jan 11 Nov ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) 02/10/21 Tilray jumps as Reddit crowd turns attention to pot, Bloomberg says 01/08/21 Deal to legalize marijuana in New Jersey suddenly collapses, NJ.com says 01/05/21 NY lawmakers file marijuana bill for 2021 session, Marijuana Moment says 12/30/20 Mexico on track to become largest legal cannabis market, WSJ reports ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) 02/18/21 Rising High: An exclusive talk with multinational cannabis company Clever Leaves 02/11/21 Rising High: An exclusive talk with biotech company Enveric Biosciences 02/11/21 Tilray, other pot stocks slide as Reddit trade loses momentum 02/04/21 Rising High: An exclusive talk with health and wellness CBD company HempFusion ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) 02/11/21 Aurora Cannabis options imply 26.2% move in share price post-earnings 02/10/21 Aurora Cannabis call volume above normal and directionally bullish 02/09/21 Aurora Cannabis call volume above normal and directionally bullish 02/08/21 Aurora Cannabis call volume above normal and directionally bullish

Over a week ago
Hot Stocks	NJ Governor signs bill to legalize adult-use cannabis » 13:15 02/22/21 02/22 13:15 02/22/21 13:15 ACB Aurora Cannabis $11.95 / -0.25 (-2.05%) , CGC Canopy Growth $37.80 / -0.83 (-2.15%) , IGC India Globalization Capital $2.05 / -0.015 (-0.73%) , CANN General Cannabis $0.00 / + (+0.00%) , ZYNE Zynerba $5.30 / -0.11 (-2.03%) , CRON Cronos Group $11.93 / -0.36 (-2.93%) , TLRY Tilray $28.43 / -0.78 (-2.67%) , CVSI CV Sciences $0.00 / + (+0.00%) , CNTTF CannTrust Holdings $0.00 / + (+0.00%) , APHA Aphria $20.11 / -0.14 (-0.69%) , TCNNF Trulieve Cannabis $0.00 / + (+0.00%) New Jersey Governor Phil… New Jersey Governor Phil Murphy said he has signed "historic" legislation to legalize adult-use cannabis, decriminalize marijuana possession in small amounts, limit the use of previous marijuana convictions, and create a regulated cannabis marketplace. "I'm grateful to all our legislative partners who put so much into this process," Murphy said. "I thank all the allies across the spectrum of social justice, and the many leaders of our communities of faith, who joined us in this work." Murphy added that, starting immediately, "those who had been subject to an arrest for petty marijuana possession will be able to get relief and move forward." Publicly traded companies in the space include Aphria (APHA), Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC), Tilray (TLRY), Trulieve Cannabis (TCNNF) and Zynerba (ZYNE). Reference Link ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ZYNE TLRY TCNNF IGC CVSI CRON CGC CANN APHA ACB ZYNE Zynerba $5.30 / -0.11 (-2.03%) 12/17/20 Zynerba announces development plan for Zygel 12/17/20 Zynerba provides regulatory update on Zygel in Fragile X syndrome 12/10/20 Immunome appoints Richard Baron to board, Stoneman as Chief Legal Officer TLRY Tilray $28.43 / -0.78 (-2.67%) 02/17/21 Pathway Health announces research collaboration with Tilray 02/09/21 Tilray jumps 19% to $35.91 after distribution agreement with Grow Pharma 02/09/21 Tilray announces import, distribution agreement with Grow Pharma 02/04/21 Tilray exports first shipment of medical cannabis to Spain TCNNF Trulieve Cannabis $0.00 / + (+0.00%) 02/01/21 Trulieve awarded dispensary permits in West Virginia IGC India Globalization Capital $2.05 / -0.015 (-0.73%) 11/24/20 Cannabis stocks soar as Trump approves start of transition to Biden 11/23/20 IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients 11/23/20 IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients CVSI CV Sciences $0.00 / + (+0.00%) 01/05/21 CV Sciences launches ProCBD product line 12/08/20 CV Sciences enters common stock purchase agreement with Tumim Stone 11/04/20 CV Sciences launches PlusCBD pet product line CRON Cronos Group $11.93 / -0.36 (-2.93%) 10/05/20 Cronos Group launches PEACE NATURALS brand in Israel 09/09/20 Cronos Group appoints Kurt Schmidt as CEO CGC Canopy Growth $37.80 / -0.83 (-2.15%) 02/18/21 Canopy Rivers gains court approval for arrangement with Canopy Growth 01/26/21 Canopy Growth launches new line Martha Stewart CBD for Pet 01/14/21 Canopy Growth files early warning report regarding TerrAscend Corp. 01/07/21 Constellation recognized $770M increase in fair value of Canopy investments CANN General Cannabis $0.00 / + (+0.00%) 01/04/21 General Cannabis raises over $2.9M of senior convertible promissory notes 09/14/20 General Cannabis appoints Diane Jones as CFO APHA Aphria $20.11 / -0.14 (-0.69%) 02/08/21 Aphria strengthens leadership position in Germany 01/14/21 Aphria jumps 6.5% to $10.65 after posting strong Q2 results 01/14/21 Aphria CEO says 'we are pleased with our second quarter results' 12/16/20 Aphria, Tilray announce $3.9B combination ACB Aurora Cannabis $11.95 / -0.25 (-2.05%) 02/11/21 Aurora Cannabis jumps 10% to $15.90 after reporting Q2 results 02/11/21 Aurora Cannabis CEO: Aurora had an excellent second quarter 02/11/21 Aurora Cannabis falls -20.3% 02/11/21 Aurora Cannabis falls -10.8% ACB CGC IGC CANN ZYNE CRON TLRY CVSI CNTTF APHA TCNNF ACB Aurora Cannabis $11.95 / -0.25 (-2.05%) 02/16/21 CIBC Aurora Cannabis price target raised to C$18.50 from C$17 at CIBC 02/16/21 GLJ Research Aurora Cannabis shares have 100% downside by end of 2022, says GLJ Research 02/12/21 Canaccord Aurora Cannabis price target raised to C$14 from C$11 at Canaccord 02/12/21 MKM Partners Aurora Cannabis downgraded to Sell from Neutral at MKM Partners CGC Canopy Growth $37.80 / -0.83 (-2.15%) 02/11/21 Desjardins Canopy Growth price target raised to C$55 from C$22 at Desjardins 02/10/21 CIBC Canopy Growth price target raised to C$64 from C$32 at CIBC 02/10/21 Cormark Canopy Growth downgraded to Reduce from Market Perform at Cormark 02/10/21 Fly Intel: Top five analyst downgrades IGC India Globalization Capital $2.05 / -0.015 (-0.73%) 02/02/21 Craig-Hallum Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum 01/29/21 Stifel 'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel 12/04/20 Alliance Global Partners Alliance Global sees low odds of MORE Act passing this congressional session 12/02/20 Alliance Global Partners Alliance Global Partners sees UN cannabis reclassification helping legalization CANN General Cannabis $0.00 / + (+0.00%) ZYNE Zynerba $5.30 / -0.11 (-2.03%) 02/03/21 Ladenburg Jazz deal for GW 'spotlights' value of Zynerba CBD products, says Ladenburg 12/21/20 H.C. Wainwright Zynerba price target lowered to $9 from $12 at H.C. Wainwright CRON Cronos Group $11.93 / -0.36 (-2.93%) 02/22/21 CIBC Cronos Group downgraded to Neutral from Outperformer at CIBC 01/06/21 BMO Capital Federal cannabis reform in U.S. likely to take time, says BMO Capital TLRY Tilray $28.43 / -0.78 (-2.67%) 02/18/21 Fly Intel: Top five analyst downgrades 02/18/21 Roth Capital Tilray price target raised to $25 from $10 at Roth Capital 02/18/21 Alliance Global Partners Tilray price target raised to $32 from $18 at Alliance Global Partners 02/18/21 BMO Capital Tilray price target raised to $22 from $9 at BMO Capital CVSI CV Sciences $0.00 / + (+0.00%) 01/29/21 Cantor Fitzgerald CV Sciences downgraded to Neutral from Overweight at Cantor Fitzgerald 01/29/21 Cantor Fitzgerald CV Sciences downgraded to Neutral from Overweight at Cantor Fitzgerald CNTTF CannTrust Holdings $0.00 / + (+0.00%) APHA Aphria $20.11 / -0.14 (-0.69%) 02/22/21 CIBC Aphria price target raised to C$28 from C$18 at CIBC 02/18/21 Piper Sandler Tilray downgraded to Neutral from Overweight at Piper Sandler TCNNF Trulieve Cannabis $0.00 / + (+0.00%) 02/04/21 Roth Capital Trulieve Cannabis initiated with a Buy at Roth Capital 01/19/21 Needham Trulieve Cannabis price target raised to $60.50 from $36.25 at Needham ZYNE TLRY TCNNF IGC CRON CGC APHA ACB ZYNE Zynerba $5.30 / -0.11 (-2.03%) 11/09/20 Zynerba reports Q3 EPS (31c), consensus (43c) TLRY Tilray $28.43 / -0.78 (-2.67%) 02/17/21 Tilray reports Q4 EPS (2c), consensus (15c) 11/09/20 Tilray sees positive or break even adjusted EBITDA in Q4 11/09/20 Tilray reports Q3 EPS (2c), consensus (21c) TCNNF Trulieve Cannabis $0.00 / + (+0.00%) 11/17/20 Trulieve Cannabis reports Q3 EPS 15c IGC India Globalization Capital $2.05 / -0.015 (-0.73%) 08/26/20 Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219 CRON Cronos Group $11.93 / -0.36 (-2.93%) 11/05/20 Cronos Group reports Q3 revenue $11.36M vs. $5.79M a year ago CGC Canopy Growth $37.80 / -0.83 (-2.15%) 02/09/21 Canopy Growth reports Q3 EPS (C$2.43) vs (C$0.26) last year 01/07/21 Constellation Brands reports Q3 adjusted EPS ex. Canopy $3.16, consensus $2.39 11/09/20 Canopy Growth reports Q2 EPS (C$0.09) vs. C$0.25 last year 10/01/20 Constellation Brands reports Q2 comparable EPS ex. Canopy Growth losses $2.91 APHA Aphria $20.11 / -0.14 (-0.69%) 01/14/21 Aphria reports Q2 adjusted EPS C$0.01 vs. (C$0.19) a year ago 10/15/20 Aphria reports Q1 EPS (C$0.02) vs. C$0.07 year ago ACB Aurora Cannabis $11.95 / -0.25 (-2.05%) 02/11/21 Aurora Cannabis reports Q2 revenue C$67.67M, vs. C$55.14M a year ago 11/09/20 Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4 10/30/20 Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance 09/22/20 Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4 22 Jan 11 Nov TLRY IGC CNTTF CGC ACB TLRY Tilray $28.43 / -0.78 (-2.67%) 01/27/21 Tilray sees U.S. legalization of cannabis within two years, CNBC reports 01/27/21 Tilray CEO offers advice to GameStop, AMC bosses amid short squeeze, CNBC says IGC India Globalization Capital $2.05 / -0.015 (-0.73%) 12/17/20 NJ lawmakers pass legal weed bill, now goes to Gov. Murphy, NJ.com reports CNTTF CannTrust Holdings $0.00 / + (+0.00%) 12/02/20 Cannabis reclassified by UN on WHO recommendation, Marijuana Business Daily says CGC Canopy Growth $37.80 / -0.83 (-2.15%) 01/08/21 Canopy Growth CEO expects to enter U.S. market within a year, Bloomberg says ACB Aurora Cannabis $11.95 / -0.25 (-2.05%) 02/10/21 Tilray jumps as Reddit crowd turns attention to pot, Bloomberg says 01/08/21 Deal to legalize marijuana in New Jersey suddenly collapses, NJ.com says 01/05/21 NY lawmakers file marijuana bill for 2021 session, Marijuana Moment says 12/30/20 Mexico on track to become largest legal cannabis market, WSJ reports TLRY IGC CGC ACB TLRY Tilray $28.43 / -0.78 (-2.67%) 02/18/21 Wells Fargo, Seagate upgrades among today's top calls on Wall Street 02/17/21 Fly Intel: After-Hours Movers IGC India Globalization Capital $2.05 / -0.015 (-0.73%) 01/28/21 Rising High: An exclusive talk with biopharmaceutical company Skye Bioscience CGC Canopy Growth $37.80 / -0.83 (-2.15%) 02/10/21 Lithia Motors, Canopy Growth downgrades among today's top calls on Wall Street ACB Aurora Cannabis $11.95 / -0.25 (-2.05%) 02/18/21 Rising High: An exclusive talk with multinational cannabis company Clever Leaves 02/11/21 Rising High: An exclusive talk with biotech company Enveric Biosciences 02/11/21 Tilray, other pot stocks slide as Reddit trade loses momentum 02/04/21 Rising High: An exclusive talk with health and wellness CBD company HempFusion 03/15/21 33rd Annual Roth Virtual Conference 02/26/21 Cronos Group - CRON ZYNE TLRY IGC CRON CGC APHA ACB ZYNE Zynerba $5.30 / -0.11 (-2.03%) 02/18/21 Zynerba call volume above normal and directionally bullish 02/18/21 Largest borrow rate increases among liquid names TLRY Tilray $28.43 / -0.78 (-2.67%) 02/17/21 Tilray options imply 24.1% move in share price post-earnings 02/12/21 Notable open interest changes for February 12th 02/03/21 Tilray call volume above normal and directionally bullish IGC India Globalization Capital $2.05 / -0.015 (-0.73%) 02/17/21 Largest borrow rate increases among liquid names 02/16/21 Largest borrow rate increases among liquid names 11/20/20 Largest borrow rate increases among liquid names 11/17/20 India Globalization Capital options imply 25.9% move in share price post-earnings CRON Cronos Group $11.93 / -0.36 (-2.93%) 02/09/21 Cronos Group call volume above normal and directionally bullish 02/02/21 Cronos Group call volume above normal and directionally bullish 01/29/21 Cronos Group call volume above normal and directionally bullish 01/13/21 Cronos Group call volume above normal and directionally bullish CGC Canopy Growth $37.80 / -0.83 (-2.15%) 02/01/21 Largest borrow rate increases among liquid names 01/13/21 Canopy Growth call volume above normal and directionally bullish 12/02/20 Canopy Growth call volume above normal and directionally bullish 11/27/20 Canopy Growth call volume above normal and directionally bullish APHA Aphria $20.11 / -0.14 (-0.69%) 02/12/21 Aphria call volume above normal and directionally bullish 02/09/21 Aphria call volume above normal and directionally bullish 01/13/21 Aphria call volume above normal and directionally bullish 01/04/21 Aphria call volume above normal and directionally bullish ACB Aurora Cannabis $11.95 / -0.25 (-2.05%) 02/11/21 Aurora Cannabis options imply 26.2% move in share price post-earnings 02/10/21 Aurora Cannabis call volume above normal and directionally bullish 02/09/21 Aurora Cannabis call volume above normal and directionally bullish 02/08/21 Aurora Cannabis call volume above normal and directionally bullish
On The Fly	Rising High: An exclusive talk with multinational cannabis company Clever Leaves » 12:09 02/18/21 02/18 12:09 02/18/21 12:09 ZYNE Zynerba $5.72 / +0.1 (+1.78%) , TCNNF Trulieve Cannabis $0.00 / + (+0.00%) , TLRY Tilray $32.37 / +0.83 (+2.63%) , IGC India Globalization Capital $2.09 / +0.075 (+3.72%) , CANN General Cannabis $0.00 / + (+0.00%) , CRON Cronos Group $12.26 / -0.21 (-1.68%) , CGC Canopy Growth $39.16 / -1.33 (-3.28%) , CTST CannTrust $0.64 / + (+0.00%) , CVSI CV Sciences $0.00 / + (+0.00%) , ACB Aurora Cannabis $12.66 / -0.41 (-3.14%) , APHA Aphria $21.09 / +0.48 (+2.33%) , GWPH GW Pharmaceuticals $214.34 / -0.07 (-0.03%) , JAZZ Jazz Pharmaceuticals $159.42 / -4.94 (-3.01%) , CLVR Clever Leaves $16.37 / -0.89 (-5.16%) In this edition of… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ZYNE TLRY TCNNF JAZZ IGC GWPH CVSI CTST CRON CLVR CGC CANN APHA ACB ZYNE Zynerba $5.72 / +0.1 (+1.78%) 12/17/20 Zynerba announces development plan for Zygel 12/17/20 Zynerba provides regulatory update on Zygel in Fragile X syndrome 12/10/20 Immunome appoints Richard Baron to board, Stoneman as Chief Legal Officer 11/24/20 Cannabis stocks soar as Trump approves start of transition to Biden TLRY Tilray $32.37 / +0.83 (+2.63%) 02/17/21 Pathway Health announces research collaboration with Tilray 02/09/21 Tilray jumps 19% to $35.91 after distribution agreement with Grow Pharma 02/09/21 Tilray announces import, distribution agreement with Grow Pharma 02/04/21 Tilray exports first shipment of medical cannabis to Spain TCNNF Trulieve Cannabis $0.00 / + (+0.00%) 02/01/21 Trulieve awarded dispensary permits in West Virginia JAZZ Jazz Pharmaceuticals $159.42 / -4.94 (-3.01%) 02/16/21 Jazz completes rolling submission for sNDA to FDA for Xywav oral solution IGC India Globalization Capital $2.09 / +0.075 (+3.72%) 11/23/20 IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients 11/23/20 IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients GWPH GW Pharmaceuticals $214.34 / -0.07 (-0.03%) 02/03/21 GW Pharmaceuticals trading resumes 02/03/21 Jazz, GW Pharmaceuticals combo expected to accretive in first full year 02/03/21 Jazz Pharmaceuticals to acquire GW Pharmaceuticals for $220.00 per ADS 02/03/21 Jazz Pharmaceuticals to acquire GW Pharmaceuticals for $220.00 per ADS CVSI CV Sciences $0.00 / + (+0.00%) 01/05/21 CV Sciences launches ProCBD product line 12/08/20 CV Sciences enters common stock purchase agreement with Tumim Stone 11/04/20 CV Sciences launches PlusCBD pet product line CTST CannTrust $0.64 / + (+0.00%) 01/08/21 CannTrust launches new medical brand, estora 12/02/20 CannTrust returns to Canadian marketplace with two recreational brands CRON Cronos Group $12.26 / -0.21 (-1.68%) 10/05/20 Cronos Group launches PEACE NATURALS brand in Israel 09/09/20 Cronos Group appoints Kurt Schmidt as CEO CLVR Clever Leaves $16.37 / -0.89 (-5.16%) 02/17/21 Clever Leaves added to NYSE-listed cannabis ETF 'THCX' 02/09/21 Clever Leaves' nutraceutical manufacturer importing CBD into U.S. 01/12/21 Clever Leaves signs multi-year partnership with Entourage Phytolab CGC Canopy Growth $39.16 / -1.33 (-3.28%) 01/26/21 Canopy Growth launches new line Martha Stewart CBD for Pet 01/14/21 Canopy Growth files early warning report regarding TerrAscend Corp. 01/07/21 Constellation recognized $770M increase in fair value of Canopy investments 12/21/20 Canopy Growth to have no interest in Canopy Rivers following Plan of Arrangement CANN General Cannabis $0.00 / + (+0.00%) 01/04/21 General Cannabis raises over $2.9M of senior convertible promissory notes 09/14/20 General Cannabis appoints Diane Jones as CFO APHA Aphria $21.09 / +0.48 (+2.33%) 02/08/21 Aphria strengthens leadership position in Germany 01/14/21 Aphria jumps 6.5% to $10.65 after posting strong Q2 results 01/14/21 Aphria CEO says 'we are pleased with our second quarter results' 12/16/20 Aphria, Tilray announce $3.9B combination ACB Aurora Cannabis $12.66 / -0.41 (-3.14%) 02/11/21 Aurora Cannabis jumps 10% to $15.90 after reporting Q2 results 02/11/21 Aurora Cannabis CEO: Aurora had an excellent second quarter 02/11/21 Aurora Cannabis falls -20.3% 02/11/21 Aurora Cannabis falls -10.8% ZYNE TCNNF TLRY IGC CANN CRON CGC CTST CVSI ACB APHA GWPH JAZZ CLVR ZYNE Zynerba $5.72 / +0.1 (+1.78%) 02/03/21 Ladenburg Jazz deal for GW 'spotlights' value of Zynerba CBD products, says Ladenburg 02/02/21 Craig-Hallum Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum 01/29/21 Stifel 'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel 12/21/20 H.C. Wainwright Zynerba price target lowered to $9 from $12 at H.C. Wainwright TCNNF Trulieve Cannabis $0.00 / + (+0.00%) 02/04/21 Roth Capital Trulieve Cannabis initiated with a Buy at Roth Capital 01/19/21 Needham Trulieve Cannabis price target raised to $60.50 from $36.25 at Needham TLRY Tilray $32.37 / +0.83 (+2.63%) 02/18/21 Fly Intel: Top five analyst downgrades 02/18/21 Roth Capital Tilray price target raised to $25 from $10 at Roth Capital 02/18/21 Alliance Global Partners Tilray price target raised to $32 from $18 at Alliance Global Partners 02/18/21 BMO Capital Tilray price target raised to $22 from $9 at BMO Capital IGC India Globalization Capital $2.09 / +0.075 (+3.72%) 12/04/20 Alliance Global Partners Alliance Global sees low odds of MORE Act passing this congressional session 12/02/20 Alliance Global Partners Alliance Global Partners sees UN cannabis reclassification helping legalization CANN General Cannabis $0.00 / + (+0.00%) CRON Cronos Group $12.26 / -0.21 (-1.68%) 01/06/21 BMO Capital Federal cannabis reform in U.S. likely to take time, says BMO Capital CGC Canopy Growth $39.16 / -1.33 (-3.28%) 02/11/21 Desjardins Canopy Growth price target raised to C$55 from C$22 at Desjardins 02/10/21 CIBC Canopy Growth price target raised to C$64 from C$32 at CIBC 02/10/21 Cormark Canopy Growth downgraded to Reduce from Market Perform at Cormark 02/10/21 Fly Intel: Top five analyst downgrades CTST CannTrust $0.64 / + (+0.00%) CVSI CV Sciences $0.00 / + (+0.00%) 01/29/21 Cantor Fitzgerald CV Sciences downgraded to Neutral from Overweight at Cantor Fitzgerald 01/29/21 Cantor Fitzgerald CV Sciences downgraded to Neutral from Overweight at Cantor Fitzgerald ACB Aurora Cannabis $12.66 / -0.41 (-3.14%) 02/16/21 CIBC Aurora Cannabis price target raised to C$18.50 from C$17 at CIBC 02/16/21 GLJ Research Aurora Cannabis shares have 100% downside by end of 2022, says GLJ Research 02/12/21 Canaccord Aurora Cannabis price target raised to C$14 from C$11 at Canaccord 02/12/21 MKM Partners Aurora Cannabis downgraded to Sell from Neutral at MKM Partners APHA Aphria $21.09 / +0.48 (+2.33%) 02/18/21 Piper Sandler Tilray downgraded to Neutral from Overweight at Piper Sandler GWPH GW Pharmaceuticals $214.34 / -0.07 (-0.03%) 02/05/21 H.C. Wainwright Jazz Pharmaceuticals price target raised to $207 from $195 at H.C. Wainwright 02/04/21 SVB Leerink GW Pharmaceuticals downgraded to Market Perform from Outperform at SVB Leerink 02/04/21 GW Pharmaceuticals downgraded to Neutral from Buy at Citi 02/04/21 H.C. Wainwright GW Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright JAZZ Jazz Pharmaceuticals $159.42 / -4.94 (-3.01%) CLVR Clever Leaves $16.37 / -0.89 (-5.16%) ZYNE TLRY TCNNF JAZZ GWPH CRON CGC APHA ACB ZYNE Zynerba $5.72 / +0.1 (+1.78%) 11/09/20 Zynerba reports Q3 EPS (31c), consensus (43c) 08/26/20 Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219 TLRY Tilray $32.37 / +0.83 (+2.63%) 02/17/21 Tilray reports Q4 EPS (2c), consensus (15c) 11/09/20 Tilray sees positive or break even adjusted EBITDA in Q4 11/09/20 Tilray reports Q3 EPS (2c), consensus (21c) TCNNF Trulieve Cannabis $0.00 / + (+0.00%) 11/17/20 Trulieve Cannabis reports Q3 EPS 15c JAZZ Jazz Pharmaceuticals $159.42 / -4.94 (-3.01%) 11/02/20 Jazz Pharma narrows FY20 non-GAAP EPS view to $12.20-$13.00 from $11.90-$13.00 11/02/20 Jazz Pharmaceuticals reports Q3 EPS $4.31, consensus $4.08 GWPH GW Pharmaceuticals $214.34 / -0.07 (-0.03%) 02/16/21 GW Pharmaceuticals reports Q4 EPS (8c), consensus (60c) 01/11/21 GW Pharmaceuticals sees 2020 revenue $526M, consensus $519.52M 01/11/21 GW Pharmaceuticals sees Q4 revenue $148M, consensus $140.44M 11/03/20 GW Pharmaceuticals reports Q3 EPS (3c), consensus (83c) CRON Cronos Group $12.26 / -0.21 (-1.68%) 11/05/20 Cronos Group reports Q3 revenue $11.36M vs. $5.79M a year ago CGC Canopy Growth $39.16 / -1.33 (-3.28%) 02/09/21 Canopy Growth reports Q3 EPS (C$2.43) vs (C$0.26) last year 01/07/21 Constellation Brands reports Q3 adjusted EPS ex. Canopy $3.16, consensus $2.39 11/09/20 Canopy Growth reports Q2 EPS (C$0.09) vs. C$0.25 last year 10/01/20 Constellation Brands reports Q2 comparable EPS ex. Canopy Growth losses $2.91 APHA Aphria $21.09 / +0.48 (+2.33%) 01/14/21 Aphria reports Q2 adjusted EPS C$0.01 vs. (C$0.19) a year ago 10/15/20 Aphria reports Q1 EPS (C$0.02) vs. C$0.07 year ago ACB Aurora Cannabis $12.66 / -0.41 (-3.14%) 02/11/21 Aurora Cannabis reports Q2 revenue C$67.67M, vs. C$55.14M a year ago 11/09/20 Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4 10/30/20 Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance 09/22/20 Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4 22 Jan 11 Nov ZYNE TLRY TCNNF GWPH CTST CGC ZYNE Zynerba $5.72 / +0.1 (+1.78%) 02/10/21 Tilray jumps as Reddit crowd turns attention to pot, Bloomberg says 01/08/21 Deal to legalize marijuana in New Jersey suddenly collapses, NJ.com says 01/05/21 NY lawmakers file marijuana bill for 2021 session, Marijuana Moment says 12/30/20 Mexico on track to become largest legal cannabis market, WSJ reports TLRY Tilray $32.37 / +0.83 (+2.63%) 01/27/21 Tilray sees U.S. legalization of cannabis within two years, CNBC reports 01/27/21 Tilray CEO offers advice to GameStop, AMC bosses amid short squeeze, CNBC says TCNNF Trulieve Cannabis $0.00 / + (+0.00%) 12/17/20 NJ lawmakers pass legal weed bill, now goes to Gov. Murphy, NJ.com reports GWPH GW Pharmaceuticals $214.34 / -0.07 (-0.03%) 11/05/20 Governor Cuomo says NY 'ripe' for pot legalization, amNewYork says 11/04/20 Marijuana legalization measures set to pass in five states, Tech Crunch says CTST CannTrust $0.64 / + (+0.00%) 10/09/20 Cannabis stocks jump after Harris vows decriminalization, Reuters reports CGC Canopy Growth $39.16 / -1.33 (-3.28%) 01/08/21 Canopy Growth CEO expects to enter U.S. market within a year, Bloomberg says ZYNE TLRY TCNNF GWPH CGC ZYNE Zynerba $5.72 / +0.1 (+1.78%) 02/18/21 Rising High: An exclusive talk with multinational cannabis company Clever Leaves 02/11/21 Rising High: An exclusive talk with biotech company Enveric Biosciences 02/11/21 Tilray, other pot stocks slide as Reddit trade loses momentum 02/04/21 Rising High: An exclusive talk with health and wellness CBD company HempFusion TLRY Tilray $32.37 / +0.83 (+2.63%) 02/18/21 Wells Fargo, Seagate upgrades among today's top calls on Wall Street 02/17/21 Fly Intel: After-Hours Movers TCNNF Trulieve Cannabis $0.00 / + (+0.00%) 01/28/21 Rising High: An exclusive talk with biopharmaceutical company Skye Bioscience GWPH GW Pharmaceuticals $214.34 / -0.07 (-0.03%) 02/03/21 Fly Intel: Wall Street's top stories for Wednesday 02/03/21 Fly Intel: Wall Street's top stories at midday CGC Canopy Growth $39.16 / -1.33 (-3.28%) 02/10/21 Lithia Motors, Canopy Growth downgrades among today's top calls on Wall Street 03/02/21 41st Annual Healthcare Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference 02/23/21 Jazz Pharmaceuticals - JAZZ 02/26/21 Cronos Group - CRON ZYNE TLRY IGC GWPH CRON CGC APHA ACB ZYNE Zynerba $5.72 / +0.1 (+1.78%) 02/18/21 Largest borrow rate increases among liquid names TLRY Tilray $32.37 / +0.83 (+2.63%) 02/17/21 Tilray options imply 24.1% move in share price post-earnings 02/16/21 Largest borrow rate increases among liquid names 02/12/21 Notable open interest changes for February 12th 02/03/21 Tilray call volume above normal and directionally bullish IGC India Globalization Capital $2.09 / +0.075 (+3.72%) 02/17/21 Largest borrow rate increases among liquid names 11/20/20 Largest borrow rate increases among liquid names 11/17/20 India Globalization Capital options imply 25.9% move in share price post-earnings GWPH GW Pharmaceuticals $214.34 / -0.07 (-0.03%) 02/11/21 Largest borrow rate increases among liquid names 02/10/21 Largest borrow rate increases among liquid names CRON Cronos Group $12.26 / -0.21 (-1.68%) 02/09/21 Cronos Group call volume above normal and directionally bullish 02/02/21 Cronos Group call volume above normal and directionally bullish 01/29/21 Cronos Group call volume above normal and directionally bullish 01/13/21 Cronos Group call volume above normal and directionally bullish CGC Canopy Growth $39.16 / -1.33 (-3.28%) 02/01/21 Largest borrow rate increases among liquid names 01/13/21 Canopy Growth call volume above normal and directionally bullish 12/02/20 Canopy Growth call volume above normal and directionally bullish 11/27/20 Canopy Growth call volume above normal and directionally bullish APHA Aphria $21.09 / +0.48 (+2.33%) 02/12/21 Aphria call volume above normal and directionally bullish 02/09/21 Aphria call volume above normal and directionally bullish 01/13/21 Aphria call volume above normal and directionally bullish 01/04/21 Aphria call volume above normal and directionally bullish ACB Aurora Cannabis $12.66 / -0.41 (-3.14%) 02/11/21 Aurora Cannabis options imply 26.2% move in share price post-earnings 02/10/21 Aurora Cannabis call volume above normal and directionally bullish 02/09/21 Aurora Cannabis call volume above normal and directionally bullish 02/08/21 Aurora Cannabis call volume above normal and directionally bullish
Recommendations	Aurora Cannabis price target raised to C$18.50 from C$17 at CIBC » 13:07 02/16/21 02/16 13:07 02/16/21 13:07 ACB Aurora Cannabis $13.48 / +1.005 (+8.06%) CIBC analyst John Zamparo… CIBC analyst John Zamparo raised the firm's price target on Aurora Cannabis to C$18.50 from C$17 and keeps a Neutral rating on the shares. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options ACB Aurora Cannabis $13.48 / +1.005 (+8.06%) 02/11/21 Aurora Cannabis jumps 10% to $15.90 after reporting Q2 results 02/11/21 Aurora Cannabis CEO: Aurora had an excellent second quarter 02/11/21 Aurora Cannabis falls -20.3% 02/11/21 Aurora Cannabis falls -10.8% ACB Aurora Cannabis $13.48 / +1.005 (+8.06%) 02/16/21 GLJ Research Aurora Cannabis shares have 100% downside by end of 2022, says GLJ Research 02/12/21 Canaccord Aurora Cannabis price target raised to C$14 from C$11 at Canaccord 02/12/21 MKM Partners Aurora Cannabis downgraded to Sell from Neutral at MKM Partners 02/12/21 Needham Aurora Cannabis downgraded to Underperform from Hold at Needham ACB Aurora Cannabis $13.48 / +1.005 (+8.06%) 02/11/21 Aurora Cannabis reports Q2 revenue C$67.67M, vs. C$55.14M a year ago 11/09/20 Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4 10/30/20 Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance 09/22/20 Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4 22 Jan 11 Nov ACB Aurora Cannabis $13.48 / +1.005 (+8.06%) 02/10/21 Tilray jumps as Reddit crowd turns attention to pot, Bloomberg says 01/08/21 Deal to legalize marijuana in New Jersey suddenly collapses, NJ.com says 01/05/21 NY lawmakers file marijuana bill for 2021 session, Marijuana Moment says 12/30/20 Mexico on track to become largest legal cannabis market, WSJ reports ACB Aurora Cannabis $13.48 / +1.005 (+8.06%) 02/11/21 Rising High: An exclusive talk with biotech company Enveric Biosciences 02/11/21 Tilray, other pot stocks slide as Reddit trade loses momentum 02/04/21 Rising High: An exclusive talk with health and wellness CBD company HempFusion 01/28/21 Rising High: An exclusive talk with biopharmaceutical company Skye Bioscience ACB Aurora Cannabis $13.48 / +1.005 (+8.06%) 02/11/21 Aurora Cannabis options imply 26.2% move in share price post-earnings 02/10/21 Aurora Cannabis call volume above normal and directionally bullish 02/09/21 Aurora Cannabis call volume above normal and directionally bullish 02/08/21 Aurora Cannabis call volume above normal and directionally bullish
Recommendations	Aurora Cannabis shares have 100% downside by end of 2022, says GLJ Research » 05:53 02/16/21 02/16 05:53 02/16/21 05:53 ACB Aurora Cannabis $12.48 / -1.955 (-13.55%) , TLRY Tilray $29.06 / -3.14 (-9.75%) GLJ Research analyst… GLJ Research analyst Gordon Johnson learned from speaking with the managers of the ETFMG Alternative Harvest ETF that no single security can comprise more than 10% of the index and 100% of the selling necessary to rebalance happens the day of the rebalancing. Under this backdrop, there are roughly 2.2M shares of Tilray (TLRY) that need to be sold and 2.3M shares of Aurora Cannabis (ACB) that need to be sold, Johnson tells investors in a research note. He believes "this overhang will continue to exert downward pressure" on both stock "until it is fully worked out." In addition, Aurora's fiscal Q2 results do not justify the stock "holding up at prior levels of ~$10/shr, much less the current price," says Johnson. He maintains a Sell rating on the shares with a $0 year-end 2022 price target. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options TLRY ACB TLRY Tilray $29.06 / -3.14 (-9.75%) 02/09/21 Tilray jumps 19% to $35.91 after distribution agreement with Grow Pharma 02/09/21 Tilray announces import, distribution agreement with Grow Pharma 02/04/21 Tilray exports first shipment of medical cannabis to Spain 02/01/21 Tilray's products receive market authorization in Portugal ACB Aurora Cannabis $12.48 / -1.955 (-13.55%) 02/11/21 Aurora Cannabis jumps 10% to $15.90 after reporting Q2 results 02/11/21 Aurora Cannabis CEO: Aurora had an excellent second quarter 02/11/21 Aurora Cannabis falls -20.3% 02/11/21 Aurora Cannabis falls -10.8% ACB TLRY ACB Aurora Cannabis $12.48 / -1.955 (-13.55%) 02/12/21 Canaccord Aurora Cannabis price target raised to C$14 from C$11 at Canaccord 02/12/21 MKM Partners Aurora Cannabis downgraded to Sell from Neutral at MKM Partners 02/12/21 Needham Aurora Cannabis downgraded to Underperform from Hold at Needham 02/12/21 Desjardins Aurora Cannabis downgraded to Sell from Hold at Desjardins TLRY Tilray $29.06 / -3.14 (-9.75%) 02/11/21 GLJ Research GLJ calls end to Reddit-driven Tilray rally, predicts 100% share downside 02/02/21 Craig-Hallum Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum 01/29/21 Stifel 'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel 01/15/21 Alliance Global Partners Aphria price target raised to C$20 from C$12 at Alliance Global Partners TLRY ACB TLRY Tilray $29.06 / -3.14 (-9.75%) 11/09/20 Tilray sees positive or break even adjusted EBITDA in Q4 11/09/20 Tilray reports Q3 EPS (2c), consensus (21c) 08/26/20 Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219 ACB Aurora Cannabis $12.48 / -1.955 (-13.55%) 02/11/21 Aurora Cannabis reports Q2 revenue C$67.67M, vs. C$55.14M a year ago 11/09/20 Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4 10/30/20 Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance 09/22/20 Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4 22 Jan 11 Nov TLRY ACB TLRY Tilray $29.06 / -3.14 (-9.75%) 01/27/21 Tilray sees U.S. legalization of cannabis within two years, CNBC reports 01/27/21 Tilray CEO offers advice to GameStop, AMC bosses amid short squeeze, CNBC says ACB Aurora Cannabis $12.48 / -1.955 (-13.55%) 02/10/21 Tilray jumps as Reddit crowd turns attention to pot, Bloomberg says 01/08/21 Deal to legalize marijuana in New Jersey suddenly collapses, NJ.com says 01/05/21 NY lawmakers file marijuana bill for 2021 session, Marijuana Moment says 12/30/20 Mexico on track to become largest legal cannabis market, WSJ reports TLRY ACB TLRY Tilray $29.06 / -3.14 (-9.75%) 02/09/21 Fly Intel: Wall Street's top stories for Tuesday 02/09/21 Fly Intel: Wall Street's top stories at midday ACB Aurora Cannabis $12.48 / -1.955 (-13.55%) 02/11/21 Rising High: An exclusive talk with biotech company Enveric Biosciences 02/11/21 Tilray, other pot stocks slide as Reddit trade loses momentum 02/04/21 Rising High: An exclusive talk with health and wellness CBD company HempFusion 01/28/21 Rising High: An exclusive talk with biopharmaceutical company Skye Bioscience 03/15/21 33rd Annual Roth Virtual Conference 02/17/21 Tilray - TLRY TLRY ACB TLRY Tilray $29.06 / -3.14 (-9.75%) 02/12/21 Notable open interest changes for February 12th 02/03/21 Tilray call volume above normal and directionally bullish 02/02/21 Tilray call volume above normal and directionally bullish 01/14/21 Tilray call volume above normal and directionally bullish ACB Aurora Cannabis $12.48 / -1.955 (-13.55%) 02/11/21 Aurora Cannabis options imply 26.2% move in share price post-earnings 02/10/21 Aurora Cannabis call volume above normal and directionally bullish 02/09/21 Aurora Cannabis call volume above normal and directionally bullish 02/08/21 Aurora Cannabis call volume above normal and directionally bullish

Recommendations	Aurora Cannabis price target raised to C$14 from C$11 at Canaccord » 12:40 02/12/21 02/12 12:40 02/12/21 12:40 ACB Aurora Cannabis $13.54 / -0.89 (-6.17%) Canaccord analyst Matt… Canaccord analyst Matt Bottomley raised the firm's price target on Aurora Cannabis to C$14 from C$11 and keeps a Hold rating on the shares. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options ACB Aurora Cannabis $13.54 / -0.89 (-6.17%) 02/11/21 Aurora Cannabis jumps 10% to $15.90 after reporting Q2 results 02/11/21 Aurora Cannabis CEO: Aurora had an excellent second quarter 02/11/21 Aurora Cannabis falls -20.3% 02/11/21 Aurora Cannabis falls -10.8% ACB Aurora Cannabis $13.54 / -0.89 (-6.17%) 02/12/21 MKM Partners Aurora Cannabis downgraded to Sell from Neutral at MKM Partners 02/12/21 Needham Aurora Cannabis downgraded to Underperform from Hold at Needham 02/12/21 Desjardins Aurora Cannabis downgraded to Sell from Hold at Desjardins 02/08/21 CIBC Aurora Cannabis price target raised to C$17 from C$15 at CIBC ACB Aurora Cannabis $13.54 / -0.89 (-6.17%) 02/11/21 Aurora Cannabis reports Q2 revenue C$67.67M, vs. C$55.14M a year ago 11/09/20 Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4 10/30/20 Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance 09/22/20 Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4 22 Jan 11 Nov ACB Aurora Cannabis $13.54 / -0.89 (-6.17%) 02/10/21 Tilray jumps as Reddit crowd turns attention to pot, Bloomberg says 01/08/21 Deal to legalize marijuana in New Jersey suddenly collapses, NJ.com says 01/05/21 NY lawmakers file marijuana bill for 2021 session, Marijuana Moment says 12/30/20 Mexico on track to become largest legal cannabis market, WSJ reports ACB Aurora Cannabis $13.54 / -0.89 (-6.17%) 02/11/21 Rising High: An exclusive talk with biotech company Enveric Biosciences 02/11/21 Tilray, other pot stocks slide as Reddit trade loses momentum 02/04/21 Rising High: An exclusive talk with health and wellness CBD company HempFusion 01/28/21 Rising High: An exclusive talk with biopharmaceutical company Skye Bioscience ACB Aurora Cannabis $13.54 / -0.89 (-6.17%) 02/11/21 Aurora Cannabis options imply 26.2% move in share price post-earnings 02/10/21 Aurora Cannabis call volume above normal and directionally bullish 02/09/21 Aurora Cannabis call volume above normal and directionally bullish 02/08/21 Aurora Cannabis call volume above normal and directionally bullish
Downgrade	Aurora Cannabis downgraded to Sell from Neutral at MKM Partners » 08:13 02/12/21 02/12 08:13 02/12/21 08:13 ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) MKM Partners analyst Bill… MKM Partners analyst Bill Kirk downgraded Aurora Cannabis to Sell from Neutral with an unchanged C$9.00 price target. The company's Q2 results were "concerning" as its consumer cannabis net revenue fell 17% sequentially to the lowest level since Q2 of 2019, the analyst tells investors in a research note, adding that the management's guided positive adjusted EBITDA failed to materialize and showed sequential deterioration. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/11/21 Aurora Cannabis jumps 10% to $15.90 after reporting Q2 results 02/11/21 Aurora Cannabis CEO: Aurora had an excellent second quarter 02/11/21 Aurora Cannabis falls -20.3% 02/11/21 Aurora Cannabis falls -10.8% ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/12/21 Needham Aurora Cannabis downgraded to Underperform from Hold at Needham 02/12/21 Desjardins Aurora Cannabis downgraded to Sell from Hold at Desjardins 02/08/21 CIBC Aurora Cannabis price target raised to C$17 from C$15 at CIBC 02/02/21 Craig-Hallum Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/11/21 Aurora Cannabis reports Q2 revenue C$67.67M, vs. C$55.14M a year ago 11/09/20 Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4 10/30/20 Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance 09/22/20 Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4 22 Jan 11 Nov ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/10/21 Tilray jumps as Reddit crowd turns attention to pot, Bloomberg says 01/08/21 Deal to legalize marijuana in New Jersey suddenly collapses, NJ.com says 01/05/21 NY lawmakers file marijuana bill for 2021 session, Marijuana Moment says 12/30/20 Mexico on track to become largest legal cannabis market, WSJ reports ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/11/21 Rising High: An exclusive talk with biotech company Enveric Biosciences 02/11/21 Tilray, other pot stocks slide as Reddit trade loses momentum 02/04/21 Rising High: An exclusive talk with health and wellness CBD company HempFusion 01/28/21 Rising High: An exclusive talk with biopharmaceutical company Skye Bioscience ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/11/21 Aurora Cannabis options imply 26.2% move in share price post-earnings 02/10/21 Aurora Cannabis call volume above normal and directionally bullish 02/09/21 Aurora Cannabis call volume above normal and directionally bullish 02/08/21 Aurora Cannabis call volume above normal and directionally bullish
Downgrade	Aurora Cannabis downgraded to Underperform from Hold at Needham » 07:47 02/12/21 02/12 07:47 02/12/21 07:47 ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) Needham analyst Matt… Needham analyst Matt McGinley downgraded Aurora Cannabis to Underperform from Hold. The rating changes is driven by the company's recent equity appreciation and weak operating performance, the analyst tells investors in a research note, adding that Aurora's valuation is not supported by its current growth prospects. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/11/21 Aurora Cannabis jumps 10% to $15.90 after reporting Q2 results 02/11/21 Aurora Cannabis CEO: Aurora had an excellent second quarter 02/11/21 Aurora Cannabis falls -20.3% 02/11/21 Aurora Cannabis falls -10.8% ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/12/21 Desjardins Aurora Cannabis downgraded to Sell from Hold at Desjardins 02/08/21 CIBC Aurora Cannabis price target raised to C$17 from C$15 at CIBC 02/02/21 Craig-Hallum Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum 01/29/21 Stifel 'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/11/21 Aurora Cannabis reports Q2 revenue C$67.67M, vs. C$55.14M a year ago 11/09/20 Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4 10/30/20 Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance 09/22/20 Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4 22 Jan 11 Nov ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/10/21 Tilray jumps as Reddit crowd turns attention to pot, Bloomberg says 01/08/21 Deal to legalize marijuana in New Jersey suddenly collapses, NJ.com says 01/05/21 NY lawmakers file marijuana bill for 2021 session, Marijuana Moment says 12/30/20 Mexico on track to become largest legal cannabis market, WSJ reports ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/11/21 Rising High: An exclusive talk with biotech company Enveric Biosciences 02/11/21 Tilray, other pot stocks slide as Reddit trade loses momentum 02/04/21 Rising High: An exclusive talk with health and wellness CBD company HempFusion 01/28/21 Rising High: An exclusive talk with biopharmaceutical company Skye Bioscience ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/11/21 Aurora Cannabis options imply 26.2% move in share price post-earnings 02/10/21 Aurora Cannabis call volume above normal and directionally bullish 02/09/21 Aurora Cannabis call volume above normal and directionally bullish 02/08/21 Aurora Cannabis call volume above normal and directionally bullish
Downgrade	Aurora Cannabis downgraded to Sell from Hold at Desjardins » 07:07 02/12/21 02/12 07:07 02/12/21 07:07 ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) Desjardins analyst John… Desjardins analyst John Chu downgraded Aurora Cannabis to Sell from Hold with an C$11 price target. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/11/21 Aurora Cannabis jumps 10% to $15.90 after reporting Q2 results 02/11/21 Aurora Cannabis CEO: Aurora had an excellent second quarter 02/11/21 Aurora Cannabis falls -20.3% 02/11/21 Aurora Cannabis falls -10.8% ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/08/21 CIBC Aurora Cannabis price target raised to C$17 from C$15 at CIBC 02/02/21 Craig-Hallum Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum 01/29/21 Stifel 'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel 01/06/21 BMO Capital Federal cannabis reform in U.S. likely to take time, says BMO Capital ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/11/21 Aurora Cannabis reports Q2 revenue C$67.67M, vs. C$55.14M a year ago 11/09/20 Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4 10/30/20 Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance 09/22/20 Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4 22 Jan 11 Nov ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/10/21 Tilray jumps as Reddit crowd turns attention to pot, Bloomberg says 01/08/21 Deal to legalize marijuana in New Jersey suddenly collapses, NJ.com says 01/05/21 NY lawmakers file marijuana bill for 2021 session, Marijuana Moment says 12/30/20 Mexico on track to become largest legal cannabis market, WSJ reports ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/11/21 Rising High: An exclusive talk with biotech company Enveric Biosciences 02/11/21 Tilray, other pot stocks slide as Reddit trade loses momentum 02/04/21 Rising High: An exclusive talk with health and wellness CBD company HempFusion 01/28/21 Rising High: An exclusive talk with biopharmaceutical company Skye Bioscience ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/11/21 Aurora Cannabis options imply 26.2% move in share price post-earnings 02/10/21 Aurora Cannabis call volume above normal and directionally bullish 02/09/21 Aurora Cannabis call volume above normal and directionally bullish 02/08/21 Aurora Cannabis call volume above normal and directionally bullish
Hot Stocks	Aurora Cannabis jumps 10% to $15.90 after reporting Q2 results 16:55 02/11/21 02/11 16:55 02/11/21 16:55 ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/11/21 Aurora Cannabis CEO: Aurora had an excellent second quarter 02/11/21 Aurora Cannabis falls -20.3% 02/11/21 Aurora Cannabis falls -10.8% 02/11/21 Aurora Cannabis falls -9.1% ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/08/21 CIBC Aurora Cannabis price target raised to C$17 from C$15 at CIBC 02/02/21 Craig-Hallum Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum 01/29/21 Stifel 'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel 01/06/21 BMO Capital Federal cannabis reform in U.S. likely to take time, says BMO Capital ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/11/21 Aurora Cannabis reports Q2 revenue C$67.67M, vs. C$55.14M a year ago 11/09/20 Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4 10/30/20 Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance 09/22/20 Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4 22 Jan 11 Nov ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/10/21 Tilray jumps as Reddit crowd turns attention to pot, Bloomberg says 01/08/21 Deal to legalize marijuana in New Jersey suddenly collapses, NJ.com says 01/05/21 NY lawmakers file marijuana bill for 2021 session, Marijuana Moment says 12/30/20 Mexico on track to become largest legal cannabis market, WSJ reports ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/11/21 Rising High: An exclusive talk with biotech company Enveric Biosciences 02/11/21 Tilray, other pot stocks slide as Reddit trade loses momentum 02/04/21 Rising High: An exclusive talk with health and wellness CBD company HempFusion 01/28/21 Rising High: An exclusive talk with biopharmaceutical company Skye Bioscience 02/11/21 Aurora Cannabis - ACB ACB Aurora Cannabis $14.46 / -4.44 (-23.49%) 02/11/21 Aurora Cannabis options imply 26.2% move in share price post-earnings 02/10/21 Aurora Cannabis call volume above normal and directionally bullish 02/09/21 Aurora Cannabis call volume above normal and directionally bullish 02/08/21 Aurora Cannabis call volume above normal and directionally bullish

On The Fly

News and insights, exclusive to thefly.com

20:25	Notable companies reporting before tomorrow's open»
14:05	Notable companies reporting before tomorrow's open»
14:04	Notable companies reporting after market close»
11:37	Vir Biotechnology selloff a 'terrific buying opportunity,' says H.C. Wainwright»
11:18	SOS rallies after Scorpio questions shorts, gives stock $40 valuation»

View all On The Fly Stories »

Upcoming
Events (10)

ASIX	AdvanSix - ASIX
VLO	Energy & Power Virtual Conference
CTVA ...	2021 Global Agriculture & Materials Virtual Conference
	European Medtech & Services Virtual Conference
QGEN ...	2021 London Global Healthcare Virtual Conference
EPD	26th Annual Energy Virtual Summit
EXK ...	30th Global Metals & Mining Virtual Conference
	Advances in Genome Biology & Technology: AGBT 2021 Virtual Event
TMO ...	41st Annual Healthcare Virtual Conference
BHC ...	Global High Yield & Leveraged Finance Virtual Conference

View all of today’s events »

Today’s
Syndicate (12)

GROY	IPO
OSCR	IPO
ASLN	Secondary
CDLX	Secondary
HSKA	Secondary
INDT	Secondary
MORF	Secondary
ICAD	Spot Secondary
MGY	Spot Secondary
ORC	Spot Secondary
PLXP	Spot Secondary
SSYS	Spot Secondary

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial